TissueGen to Showcase ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering at MD&M West

25 Feb TissueGen to Showcase ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering at MD&M West

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to deliver fiber and textile platforms for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedics and sutures.

WHAT: TissueGen’s patented drug delivery technology is available today as ELUTE fiber, which it will be exhibiting at MD&M West in Booth 2996. ELUTE fibers are able to be loaded with the widest range possible of drugs and biologically-derived entities, including temperature sensitive proteins, growth factors, enzymes, small molecule pharmaceuticals and viruses. ELUTE fiber is available in pharmaceutical and growth factor formats ideal for a wide variety of medical and research applications including spinal cord injury repair, tissue engineering and nerve regeneration.

By delivering drugs at the site of implantation, ELUTE fibers enable medical devices to tailor the body’s response. Frequently, localized drug delivery is preferred over systemic delivery. Additionally, TissueGen’s drug loaded biodegradable fibers stay in place once implanted. Whereas drugs injected via millions of microspheres or billions of nanoparticles cannot be retrieved from the body, implantables with ELUTE fibers may be retrieved as required by the treating physician.

TissueGen recently completed significant facility upgrades enabling it to manufacture and develop ELUTE fiber in an ISO Class 7 cleanroom environment to support the Food and Drug Administration’s cGMP regulations for manufacturing drug product. TissueGen also implemented an ISO 13485:2003 compliant quality management system to ensure quality controls and installed robust HEPA filtration systems to adhere to stringent air quality requirements.

WHERE:
MD&M West
Booth 2996
Anaheim Convention Center,
Anaheim, CA

WHEN: MD&M West will take place from February 9-11, 2016.

 To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or (401)490-9700.

About TissueGen

TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

For more information contact:

Jordan Bouclin
SVM Public Relations
401-490-9700
jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.